ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

16,826Medicare Part D Prescriptions Filled, Including Refills

Rank: 34 out of 670

$974K Total Retail Price of All Prescriptions

Rank: 40 out of 670

689 Patients Receiving at Least One Drug in Part D
87%Patients 65 Years and Older
40% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in West Virginia
Lower avg

Schedule Two
Controlled Substances

13% of this provider’s 689 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

19% of this provider’s 689 patients filled at least one prescription for a schedule three drug, compared to an average of 16%.

Risky Drugs to Seniors

1% of this provider’s 14,888 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$58 was the average price of a prescription from this provider, compared to $58 among peers.

Prescriptions per Patient

24 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in West Virginia
HYDROCODONE-ACETAMINOPHEN 656 597 S3 1 1
LEVOTHYROXINE SODIUM 577 514 2 2
FUROSEMIDE 561 521 3 6
WARFARIN SODIUM 557 520 4 13
LISINOPRIL 474 446 5 3
OMEPRAZOLE 455 375 6 5
METOPROLOL TARTRATE 451 416 7 9
AMLODIPINE BESYLATE 361 326 8 7
POTASSIUM CHLORIDE 361 332 8 16
SIMVASTATIN 351 311 10 4
SERTRALINE HCL 345 302 11 22
ZOLPIDEM TARTRATE 317 305 12 23
HYDROCHLOROTHIAZIDE 291 235 13 10
DONEPEZIL HCL 281 281 14 31
METFORMIN HCL 234 172 15 8
ATORVASTATIN CALCIUM 231 209 16 15
ALENDRONATE SODIUM 223 190 17 43
NAMENDA 218 218 18 54
GABAPENTIN 213 182 19 11
CELEBREX 202 191 20 89
PRAVASTATIN SODIUM 196 180 21 19
CYMBALTA 148 98 22 36
DIGOXIN 146 146 23 46
TRAMADOL HCL 145 121 24 21
TAMSULOSIN HCL 136 132 25 30
CARVEDILOL 133 132 26 29
METOPROLOL SUCCINATE 133 104 26 12
ALLOPURINOL 132 130 28 38
GLIMEPIRIDE 132 113 28 32
OXYCODONE-ACETAMINOPHEN 131 101 S2 30 77
LOSARTAN POTASSIUM 131 118 30 26
ATENOLOL 130 125 32 17
EXELON 121 121 33 128
PREDNISONE 111 106 34 40
TRAZODONE HCL 110 69 35 39
ZETIA 101 95 36 66
LACTULOSE 100 100 37 107
LANTUS 99 80 38 58
CITALOPRAM HBR 98 92 39 20
VENLAFAXINE HCL ER 96 84 40 97
QUETIAPINE FUMARATE 95 86 41 84
SPIRONOLACTONE 94 82 42 82
JANUVIA 93 79 43 53
AZITHROMYCIN 84 69 44 35
PAROXETINE HCL 83 83 45 52
ISOSORBIDE MONONITRATE ER 83 69 45 45
PROAIR HFA 82 59 47 28
CRESTOR 79 70 48 18
LOVASTATIN 79 69 48 44
LISINOPRIL-HYDROCHLOROTHIAZIDE 77 65 50 27
LOSARTAN-HYDROCHLOROTHIAZIDE 75 74 51 73
NOVOLOG MIX 70-30 74 59 52 249
PROBENECID 72 72 53 330
CLOPIDOGREL 71 67 54 24
RANITIDINE HCL 70 67 55 25
BUSPIRONE HCL 68 68 56 124
TORSEMIDE 68 66 56 100
PROPRANOLOL HCL 68 66 56 130
ADVAIR DISKUS 66 63 59 42
MIRTAZAPINE 66 66 59 59
FLUTICASONE PROPIONATE 65 43 61 37
PLAVIX 64 54 62 34
PANTOPRAZOLE SODIUM 61 51 63 41
FENTANYL 59 35 S2 64 76
SINGULAIR 59 43 64 56
ESCITALOPRAM OXALATE 59 48 64 78
AMITRIPTYLINE HCL 58 37 R 67 68
DIOVAN HCT 57 56 68 126
FENOFIBRATE 56 56 69 64
CIPROFLOXACIN HCL 55 48 70 60
FAMOTIDINE 55 46 70 99
DIOVAN 54 54 72 48
SYNTHROID 53 49 73 47
VENLAFAXINE HCL 53 53 73 257
QUINAPRIL HCL 52 52 75 103
GLIPIZIDE 51 42 76 67
DILTIAZEM 24HR ER 51 51 76 122
SPIRIVA 51 37 76 51
COUMADIN 50 50 79 239
NAPROXEN 50 41 79 81
TAMIFLU 50 48 79 209
NIASPAN 50 44 79 116
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 4, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.